Sidoti Events, LLC's Year-End Virtual Investor Conference
AI Sentiment
Positive
6/10
as of 12-15-2025 3:30pm EST
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
| Founded: | 2014 | Country: | Hong Kong |
| Employees: | N/A | City: | N/A |
| Market Cap: | 131.3M | IPO Year: | N/A |
| Target Price: | $32.00 | AVG Volume (30 days): | 137.5K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.10 - $17.99 | Next Earning Date: | 11-10-2025 |
| Revenue: | $77,079,000 | Revenue Growth: | 201.54% |
| Revenue Growth (this year): | 219.28% | Revenue Growth (next year): | 124.38% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
PRE Breaking Stock News: Dive into PRE Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
6/10
See how PRE stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PRE Prenetics Global Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.